You can buy or sell Veracyte and other stocks, options, and ETFs commission-free!
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA. The listed name for VCYT is Veracyte, Inc. Common Stock.
Bonnie H. Anderson
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Feb 23, After Hours